{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:25:11Z","timestamp":1793384711885,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Epidemiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.gloepi.2023.100098","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T12:42:58Z","timestamp":1673440978000},"page":"100098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Incidence of Guillain-Barr\u00e9 syndrome in the world between 1985 and 2020: A systematic review"],"prefix":"10.1016","volume":"5","author":[{"given":"Virginia Kagure","family":"Wachira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia Menezes","family":"Farinasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Borges","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Maia","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Regina Fernandes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gloepi.2023.100098_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain\u2013Barr\u00e9 syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.gloepi.2023.100098_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gloepi.2023.100098_bb0015","series-title":"Guillain-Barr\u00e9 syndrome: Modern theories of etiology","author":"Hardy","year":"2011"},{"issue":"10280","key":"10.1016\/j.gloepi.2023.100098_bb0020","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2016.09.022","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"16","author":"Esposito","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0030","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/CON.0000000000000513","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"23","author":"Donofrio","year":"2017","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/tmi.13181","article-title":"Systematic review of factors associated with the development of Guillain\u2013Barr\u00e9 syndrome 2007\u20132017: what has changed?","volume":"24","author":"Wachira","year":"2019","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.gloepi.2023.100098_bb0040","article-title":"Guillain-Barre syndrome and its correlation with dengue, Zika and chikungunya viruses infection based on a literature review of reported cases in Brazil","volume":"197","author":"de Lima","year":"2019","journal-title":"Acta Trop"},{"issue":"9","key":"10.1016\/j.gloepi.2023.100098_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nrl.2020.07.004","article-title":"Relaci\u00f3n entre COVID-19 y s\u00edndrome de Guillain-Barr\u00e9 en adultos. Revisi\u00f3n sistem\u00e1tica","volume":"35","author":"Trujillo Gittermann","year":"2020","journal-title":"Neurolog\u00eda"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0050","article-title":"Association of Guillain-Barre syndrome with COVID-19 infection: an updated systematic review","volume":"355","author":"Sheikh","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.gloepi.2023.100098_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barre syndrom\u00e9","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"13","key":"10.1016\/j.gloepi.2023.100098_bb0060","first-page":"717","article-title":"Seminar Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"www.thelancet.com"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide: a systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.gloepi.2023.100098_bb0075","series-title":"CDC Novel H1N1 Flu | The 2009 H1N1 Pandemic","author":"CDC","year":"2010"},{"key":"10.1016\/j.gloepi.2023.100098_bb0080","series-title":"Zika Virus overview","first-page":"21","author":"Virus","year":"2021"},{"issue":"9876","key":"10.1016\/j.gloepi.2023.100098_bb0085","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza a (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-015-0047-0","article-title":"Risk of Guillain-Barr\u00e9 syndrome after exposure to pandemic influenza a(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study","volume":"31","author":"Ghaderi","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjid.2018.02.005","article-title":"Review article prevalence of Guillain-Barr\u00e9 syndrome among Zika virus infected cases\u00a0: a systematic review and meta-analysis","volume":"22","author":"Barbi","year":"2018","journal-title":"Braz J Infect Dis"},{"issue":"10027","key":"10.1016\/j.gloepi.2023.100098_bb0100","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100098_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008264","article-title":"Guillain-barr\u00e9 syndrome related to zika virus infection: a systematic review and meta-analysis of the clinical and electrophysiological phenotype","volume":"14","author":"Leonhard","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"16","key":"10.1016\/j.gloepi.2023.100098_bb0110","first-page":"1598","article-title":"Zika Virus and the Guillain\u2013Barr\u00e9 syndrome \u2014 case series from seven countries","volume":"16","author":"dos Santos","year":"2016"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007622","article-title":"Incidence of Guillain-Barr\u00e9Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: a systematic review and meta-analysis","volume":"13","author":"Capasso","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.gloepi.2023.100098_bb0120","series-title":"Epidemiology update","author":"World Health Organisation","year":"2019"},{"key":"10.1016\/j.gloepi.2023.100098_bb0125","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.gloepi.2023.100098_bb0130","series-title":"Cat\u00e1logo de Teses & Disserta\u00e7\u00f5es-CAPES, \u201cCat\u00e1logo de Teses & Disserta\u00e7\u00f5es \u2013 CAPES\u201d","volume":"2020","author":"Brasil","year":"2020"},{"key":"10.1016\/j.gloepi.2023.100098_bb0135","author":"Brasil"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/aje\/kwu322","article-title":"A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program","volume":"181","author":"Baker","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"9303","key":"10.1016\/j.gloepi.2023.100098_bb0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.36502\/2019\/ASJBCCR.6150","article-title":"Self-controlled case series study (SCCSS): a novel research method","volume":"2","author":"El-Gilany","year":"2019","journal-title":"Asploro J Biomed Clin Case Reports"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0160","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","article-title":"Cross-sectional studies: strengths, weaknesses, and recommendations","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.gloepi.2023.100098_bb0170","series-title":"JBI Manual for Evidence Synthesis","volume":"no. July","author":"Joanna Briggs Institute","year":"2020"},{"key":"10.1016\/j.gloepi.2023.100098_bb0175","series-title":"Countries and territories with current or previous Zika virus transmission by WHO regional office","first-page":"2019","volume":"no. July","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.gloepi.2023.100098_bb0180","series-title":"Oms","first-page":"171082","article-title":"Table1. Countries and territories thaht have reported mosquito-borne Zika virus transmission","volume":"no. Ihr 2005","author":"World Health Organization","year":"2016"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0185","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2010.09.020","article-title":"Guillain-Barr\u00e9 syndrome after Gardasil vaccination: data from vaccine adverse event reporting system 2006-2009","volume":"29","author":"Souayah","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100098_bb0190","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","article-title":"Cumulative risk of guillain-barr\u00e9 syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic","volume":"104","author":"Vellozzi","year":"2014","journal-title":"Am J Public Health"},{"issue":"15","key":"10.1016\/j.gloepi.2023.100098_bb0195","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.vaccine.2015.02.035","article-title":"Pandemic influenza a vaccination and incidence of Guillain-Barr\u00e9 syndrome in Korea","volume":"33","author":"Kim","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0404.2011.01503.x","article-title":"Clinical characteristics of Guillain-Barr\u00e9 syndrome in a tropical country: a Brazilian experience","volume":"125","author":"Dourado","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"10.1016\/j.gloepi.2023.100098_bb0205","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/cix588","article-title":"Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Martinique in 2016: a prospective study","volume":"65","author":"Roz\u00e9","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0210","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/ene.13569","article-title":"Guillain\u2212Barr\u00e9 syndrome in a local area in Japan, 2006\u20132015: an epidemiological and clinical study of 108 patients","volume":"25","author":"Matsui","year":"2018","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.gloepi.2023.100098_bb0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5694\/mja12.10534","article-title":"Guillain-Barr\u00e9 syndrome following pandemic (H1N1) 2009 influenza a immunisation in Victoria: a self-controlled case series","volume":"197","author":"Crawford","year":"2012","journal-title":"Med J Aust"},{"issue":"39","key":"10.1016\/j.gloepi.2023.100098_bb0220","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1016\/j.vaccine.2008.07.014","article-title":"Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5\u201314 years old children","volume":"26","author":"Esteghamati","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.gloepi.2023.100098_bb0225","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/aje\/kwt051","article-title":"Chart-confirmed guillain-Barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010","volume":"178","author":"Polakowski","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.gloepi.2023.100098_bb0230","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/aje\/kws196","article-title":"Guillain-Barr\u00e9 syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00007844","article-title":"Distinct pattern of age-specific incidence of Guillain-Barr\u00e9 syndrome in Harbin, China","volume":"249","author":"Cheng","year":"2002","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100098_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jns.12096","article-title":"Clinical and epidemiological features of Guillain-Barr\u00e9 syndrome in the Western Balkans","volume":"19","author":"Peric","year":"2014","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nrl.2014.09.007","article-title":"Incidencia y caracter\u00edsticas cl\u00ednicas del s\u00edndrome de Guillain-Barr\u00e9 en la comarca de Osona (Barcelona, Espa\u00f1a) (2003-2016)","volume":"1","author":"Aragon\u00e8s","year":"2018","journal-title":"Neurolog\u00eda"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10072-018-3688-4","article-title":"Incidence study of Guillain-Barr\u00e9 syndrome in the province of Ferrara, northern Italy, between 2003 and 2017. A 40-year follow-up","volume":"40","author":"Granieri","year":"2019","journal-title":"Neurol Sci"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100098_bb0255","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0404.1994.tb01682.x","article-title":"Guillain-Barr\u00e9 syndrome in Cantabria, Spain. An epidemiological and clinical study","volume":"89","author":"Sedano","year":"1994","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00415-018-9151-x","article-title":"Guillain\u2013Barr\u00e9 syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity","volume":"266","author":"Al-Hakem","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-1331.2000.00006.x","article-title":"Incidence of Guillain-Barr\u00e9 syndrome in Sweden 1996","volume":"7","author":"Cheng","year":"2000","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ene.12265","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome in parts of China: three large populations in Jiangsu province, 2008-2010","volume":"21","author":"Chen","year":"2014","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1529-8027.2011.00356.x","article-title":"Guillain-Barr\u00e9 syndrome: background incidence rates in the Netherlands","volume":"16","author":"Van Der Maas","year":"2011","journal-title":"J Peripher Nerv Syst"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.33588\/rn.3508.2002352","article-title":"Guillain-Barr\u00e9 syndrome in the northern area of gran Canaria and the island of Lanzarote","volume":"35","author":"Aladro-Benito","year":"2002","journal-title":"Rev Neurol"},{"issue":"6","key":"10.1016\/j.gloepi.2023.100098_bb0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-0038-1660838","article-title":"Incidence of Guillain-Barre\u2019s syndrome in children under 15 years of age in Oman","volume":"17","author":"Koul","year":"2019","journal-title":"J Pediatr Neurol"},{"key":"10.1016\/j.gloepi.2023.100098_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clineuro.2015.12.008","article-title":"Guillain Barr\u00e9 syndrome - incidence and clinical course in southern Rogaland, Norway","volume":"141","author":"Farbu","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0295","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(03)00215-6","article-title":"Is there a decrease in Guillain-Barr\u00e9 syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the local Health District of Ferrara, Italy","volume":"216","author":"Govoni","year":"2003","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0300","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","article-title":"Guillain-Barr\u00e9 syndrome (GBS)","volume":"62","author":"Pithadia","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.gloepi.2023.100098_bb0305","first-page":"545","article-title":"Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review","volume":"28","author":"Poropatich","year":"2010","journal-title":"J Heal Popul NUTR"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jns.12202","article-title":"Guillain-Barr\u00e9 syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008\u20132013)","volume":"22","author":"Delannoy","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0315","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000213529","article-title":"Guillain-Barr\u00e9 syndrome in the elderly","volume":"39","author":"Sridharan","year":"1993","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0325","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ageing\/22.3.164","article-title":"Guillain-barr\u00e9 syndrome in oxfordshire: clinical features in relation to age","volume":"22","author":"Winner","year":"1993","journal-title":"Age Ageing"},{"issue":"January","key":"10.1016\/j.gloepi.2023.100098_bb0330","first-page":"1","article-title":"The Neuroimmunology of Guillain-Barr\u00e9 syndrome and the potential role of an aging immune system","volume":"12","author":"Hagen","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"25","key":"10.1016\/j.gloepi.2023.100098_bb0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejpn.2020.01.003","article-title":"Diagnosis and treatment of Guillain-Barr\u00e9 syndrome in childhood and adolescence: an evidence- and consensus-based guideline","author":"Korinthenberg","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0340","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001432-200310000-00002","article-title":"Infectious causes of acute flaccid paralysis","volume":"16","author":"Solomon","year":"2003","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0345","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jpc.13709","article-title":"Acute flaccid paralysis in south African children: causes, respiratory complications and neurological outcome","volume":"54","author":"van der Pijl","year":"2018","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0350","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41582-021-00467-y","article-title":"Guillain\u2013Barr\u00e9 syndrome in low-income and middle-income countries: challenges and prospects","volume":"17","author":"Papri","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"10.1016\/j.gloepi.2023.100098_bb0355","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003257","article-title":"Guillain\u2013Barr\u00e9 syndrome (42 cases) occurring during a Zika virus outbreak in French Polynesia","volume":"95","author":"Watrin","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100098_bb0360","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5501\/wjv.v5.i4.135","article-title":"Neurological manifestations of Zika virus infection","volume":"5","author":"Bl\u00e1zquez","year":"2016","journal-title":"World J Virol"},{"issue":"9","key":"10.1016\/j.gloepi.2023.100098_bb0365","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100098_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0009055","article-title":"Measuring the global burden of chikungunya and Zika viruses: a systematic review","volume":"15","author":"Puntasecca","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0375","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tmi.13508","article-title":"Burden of Disease of Guillain\u2013Barr\u00e9 Syndrome in Brazil before and during the Zika virus epidemic 2014\u20132016","volume":"26","author":"Wachira","year":"2021","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100098_bb0380","first-page":"65","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977","volume":"95","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0385","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-barr\u00e9 syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"45","key":"10.1016\/j.gloepi.2023.100098_bb0390","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","article-title":"Guillain \u201cBarr syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series\u201d","volume":"29","author":"Andrews","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.gloepi.2023.100098_bb0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/ciq012","article-title":"Estimating the burden of 2009 pandemic influenza a (H1N1) in the United States (April 2009-April 2010)","volume":"52","author":"Shrestha","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.gloepi.2023.100098_bb0400","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/cid\/cir644","article-title":"Mortality burden of the a\/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza","volume":"53","author":"Charu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3988\/jcn.2021.17.2.257","article-title":"Epidemiological features and economic burden of Guillain-Barr\u00e9 syndrome in South Korea","volume":"17","author":"Ah-Young","year":"2021","journal-title":"J Clin Neurol"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0410","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s001340051323","article-title":"Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barre syndrome","volume":"26","author":"Esp\u00e9rou","year":"2000","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100098_bb0415","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/trstmh\/trz010","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with Zika virus infection in Brazil: a cost-of-illness study","volume":"113","author":"Peixoto","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"14","key":"10.1016\/j.gloepi.2023.100098_bb0420","first-page":"310","article-title":"Costs of Guillain-Barr\u00e9 syndrome in the Brazilian Federal District: the patients\u2019 perspective","volume":"116","author":"de Oliveira","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.gloepi.2023.100098_bb0425","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s00415-010-5653-x","article-title":"Factors associated with long-term functional outcomes and psychological sequelae in Guillain\u2013Barre syndrome","volume":"257","author":"Khan","year":"2010","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.gloepi.2023.100098_bb0430","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Ianca","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100098_bb0435","first-page":"7","article-title":"Impact of Guillain Barre syndrome on psychosocial functionings of patients in Islamabad","volume":"9","author":"Babur","year":"2014","journal-title":"Pak J Neurol Sci"}],"container-title":["Global Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:49:19Z","timestamp":1762912159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590113323000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":86,"alternative-id":["S2590113323000019"],"URL":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100098","relation":{},"ISSN":["2590-1133"],"issn-type":[{"value":"2590-1133","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Guillain-Barr\u00e9 syndrome in the world between 1985 and 2020: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Global Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100098"}}